Pharma Marketing Network

JANUARY 29, 2025

In 2025, pharmaceutical trends are redefining how brands connect with healthcare professionals (HCPs), patients, and stakeholders. But what exactly is shaping the future of pharma marketing this year? Brands that fail to provide consistent messaging risk losing trust and engagement.

Marketing 52

Marketing Compliance Big Data Branding 52

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

pharmaphorum

AUGUST 10, 2020

This research also shows the complex system that drives our health outcomes, including the environment, our genetics and our social circumstances. Personalisation : creating interventions based on individuals knowing their genetics, biology and psychology as well as their social and geographical environment.

Genetics 124

Genetics Drug Delivery Research Pharma Companies 124

Pharma Marketing Network

OCTOBER 17, 2024

Moreover, the adoption of digital tools like mobile apps and telemedicine platforms is facilitating direct communication between pharma companies and end-users. As patients become more digitally savvy, pharma companies are investing in creating seamless digital experiences that cater to their needs and preferences.

Marketing 52

Marketing Pharma Companies Regulation Production 52

pharmaphorum

AUGUST 11, 2020

In our latest UK Leaders article Pinder Sahota, UK general manager at Novo Nordisk, tells us how he hopes to bring the NHS and pharma together to improve outcomes in diabetes and other long-term conditions. This will also mean the industry needs to think about how HCPs will want to interact with pharma companies. “If

Pharma Companies 111

Pharma Companies Insulin Packaging Packaging 111

Pharma Marketing Network

OCTOBER 14, 2024

With advancements in genomics and biotechnology, there is a move towards tailoring treatments to individual patients based on their genetic makeup. Pharma executives must navigate these regulatory complexities while maintaining compliance to protect their brand reputation and foster trust with stakeholders.

Marketing 52

Marketing Branding Big Data Drugs 52

XTalks

DECEMBER 20, 2023

Check out this article to learn about the biotech companies that went public this year. The companies include a diverse range engaged in innovative approaches in areas like oncology, genetic medicines, inflammatory diseases, dermatology and cardiorenal therapy. billion ad impressions.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

The Pharma Data

DECEMBER 17, 2020

Most recently, Cadavid served as senior vice president and Head of Clinical Development at Fulcrum Therapeutics where he led the development of multiple small molecules for the treatment of genetically defined rare diseases. AB2 Bio – Swiss pharma company AB2 Bio Ltd. named Djordje Filipovic as its new chief commercial officer.

Development 52

Development Gene Therapy Engineer Life Science 52

XTalks

OCTOBER 1, 2020

Sooter has also found success in industry, leading and bringing together the work of different teams of researchers at NeuBase to help drive the company’s goal of developing cures and treatments for genetic diseases, including Huntington’s Disease. She says, “It’s been a lot of fun; it’s a decision I’m glad I made.”.

Scientist 52

Scientist In-Vitro Research Life Science 52

The Pharma Data

DECEMBER 30, 2020

Another Biden plan opens up foreign markets for consumers to buy their prescription drugs and calls for limiting price increases on branded drugs and generics for drugs included in the Medicare program. The board will then recommend a “reasonable price” based on the average price in other countries or, if the drug is entering the U.S.

Vaccination 52

Vaccination Vaccine Gene Therapy Trials 52

Pharma Marketing Network

DECEMBER 4, 2024

Remember, in pharma marketing, patients are not just consumers—they’re partners in health. By leveraging tools like genetic profiling and behavioral analytics, pharma marketers can craft personalized campaigns that resonate deeply. Conclusion The future of pharma marketing is exciting and filled with opportunities.

Marketing 52

Marketing Compliance Branding Regulation 52

XTalks

DECEMBER 3, 2024

From blockbuster drugs like Ozempic to foundational treatments like insulin, these therapies showcase the diverse strategies used by pharma companies to meet the needs of a rapidly growing market. Price of Insulin: Varies significantly by type and brand of insulin.

Sales 105

Sales Insulin FDA Approval Drugs 105